Format

Send to

Choose Destination
Int J Mol Sci. 2016 Jan 26;17(2). pii: E156. doi: 10.3390/ijms17020156.

miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.

Author information

1
IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg 5020, Austria. g.rinnerthaler@salk.at.
2
Salzburg Cancer Research Institute with Laboratory of Immunological and Molecular Cancer Research and Center for Clinical Cancer and Immunology Trials, Salzburg 5020, Austria. g.rinnerthaler@salk.at.
3
Cancer Cluster Salzburg, Salzburg 5020, Austria. g.rinnerthaler@salk.at.
4
Division of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck 6020, Austria. hubert.hackl@i-med.ac.at.
5
IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg 5020, Austria. s.gampenrieder@salk.at.
6
IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg 5020, Austria. Frank.Hamacher71@gmx.de.
7
IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg 5020, Austria. cl.hufnagl@salk.at.
8
Department of Pathology, Paracelsus Medical University Salzburg, Salzburg 5020, Austria. c.kronberger@salk.at.
9
Department of Radiotherapy, Paracelsus Medical University Salzburg, Salzburg 5020, Austria. f.zehentmayr@salk.at.
10
Department of Radiotherapy, Paracelsus Medical University Salzburg, Salzburg 5020, Austria. g.fastner@salk.at.
11
Department of Radiotherapy, Paracelsus Medical University Salzburg, Salzburg 5020, Austria. f.sedlmayer@salk.at.
12
IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg 5020, Austria. b.mlineritsch@salk.at.
13
Salzburg Cancer Research Institute with Laboratory of Immunological and Molecular Cancer Research and Center for Clinical Cancer and Immunology Trials, Salzburg 5020, Austria. b.mlineritsch@salk.at.
14
Cancer Cluster Salzburg, Salzburg 5020, Austria. b.mlineritsch@salk.at.
15
IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg 5020, Austria. r.greil@salk.at.
16
Salzburg Cancer Research Institute with Laboratory of Immunological and Molecular Cancer Research and Center for Clinical Cancer and Immunology Trials, Salzburg 5020, Austria. r.greil@salk.at.
17
Cancer Cluster Salzburg, Salzburg 5020, Austria. r.greil@salk.at.

Abstract

For quantitative microRNA analyses in formalin-fixed paraffin-embedded (FFPE) tissue, expression levels have to be normalized to endogenous controls. To investigate the most stably-expressed microRNAs in breast cancer and its surrounding tissue, we used tumor samples from primary tumors and from metastatic sites. MiRNA profiling using TaqMan(®) Array Human MicroRNA Cards, enabling quantification of 754 unique human miRNAs, was performed in FFPE specimens from 58 patients with metastatic breast cancer. Forty-two (72%) samples were collected from primary tumors and 16 (28%) from metastases. In a cross-platform analysis of a validation cohort of 32 FFPE samples from patients with early breast cancer genome-wide microRNA expression analysis using SurePrintG3 miRNA (8 × 60 K)(®) microarrays from Agilent(®) was performed. Eleven microRNAs could be detected in all samples analyzed. Based on NormFinder and geNorm stability values and the high correlation (rho ≥ 0.8) with the median of all measured microRNAs, miR-16-5p, miR-29a-3p, miR-126-3p, and miR-222-3p are suitable single gene housekeeper candidates. In the cross-platform validation, 29 human microRNAs were strongly expressed (mean log2-intensity > 10) and 21 of these microRNAs including miR-16-5p and miR-29a-3p were also stably expressed (CV < 5%). Thus, miR-16-5p and miR-29a-3p are both strong housekeeper candidates. Their Normfinder stability values calculated across the primary tumor and metastases subgroup indicate that miR-29a-3p can be considered as the strongest housekeeper in a cohort with mainly samples from primary tumors, whereas miR-16-5p might perform better in a metastatic sample enriched cohort.

KEYWORDS:

breast cancer; control; endogenous control; housekeeper; miR-16; miR-16-5p; microRNA

PMID:
26821018
PMCID:
PMC4783890
DOI:
10.3390/ijms17020156
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center